Dr Reddy’s stock drops over 5%

Dr Reddy's Laboratories fell by 5% amid media reports that a US drug maker has sued it.

Dr Reddy’s Laboratories stock today fell by a little over 5 per cent on Bombay Stock Exchange (BSE) amid media reports that a US drug maker has sued the company for patent infringement.

The pharma major closed 5.07 per cent down at Rs 1,599.20 on the BSE. During intra-day trade,it had shed 6.26 per cent to Rs 1,579 a piece.

Besides,the scrip closed 4.64 per cent lower at Rs 1,605 on the National Stock Exchange.

Story continues below this ad

According to media reports,New Jersey-based Medicines Co has filed a suit in a US court alleging that Dr Reddy’s is infringing its patent to make the generic version of bivalirudin,a drug used as an anticoagulant in angioplasty procedures.

Meanwhile,the BSE benchmark Sensex today closed 65.33 points,or 0.35 per cent down at 18,469.36.

The RJD’s key face and Leader of the Opposition (LoP) Tejashwi Yadav, party supremo Lalu Yadav’s son, will again contest from his stronghold Raghopur.

Amid Mahagathbandhan crisis, RJD unveils list of 143, drops 36 MLAs, focuses on ‘M-Y’

Political Pulse7 hr ago

The RJD, lead player of the Mahagathbandhan, released its full list of 143 candidates for the November Bihar Assembly elections. Its key face Tejashwi Yadav will contest from Raghopur, and 41 sitting MLAs have been renominated. The party has dropped 36 sitting MLAs and fielded young leaders, signaling a bid to consolidate its core Muslim-Yadav vote base. The Congress has fielded 60 candidates.

View all shorts

Live Blog

PHOTOS